We are live on ! Find out more
LS

Leelyn Smith Portfolio holdings

AUM $822M
1-Year Est. Return 31.69%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+31.69%
3 Year Est. Return
+77.34%
5 Year Est. Return
+91.98%
10 Year Est. Return
–
AUM
$336M
AUM Growth
+$23.3M
Cap. Flow
+$15.2M
Cap. Flow %
4.53%
Top 10 Hldgs %
40.79%
Holding
397
New
32
Increased
145
Reduced
77
Closed
9

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$2.55M
2
MRK icon
Merck
MRK
+$1.96M
3
SMMV icon
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
+$1.95M
4
BABA icon
Alibaba
BABA
+$1.9M
5
ARKK icon
ARK Innovation ETF
ARKK
+$1.66M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$2.01M
2
RTX icon
RTX Corp
RTX
+$1.65M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.17M
4
SKYY icon
First Trust Cloud Computing ETF
SKYY
+$863K
5
QQEW icon
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
+$830K

Sector Composition

Rank Sector Weight
1 Technology 10.61%
2 Healthcare 7.68%
3 Consumer Discretionary 7.22%
4 Financials 5.18%
5 Consumer Staples 5.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
26
Invesco QQQ Trust
QQQ
$485B
$3M 0.89%
9,401
+7,967
+556% +$2.55M
MA icon
27
Mastercard
MA
$524B
$2.88M 0.86%
8,085
+347
+4% +$121K
ADI icon
28
Analog Devices
ADI
$179B
$2.82M 0.84%
18,183
+806
+5% +$124K
UNH icon
29
UnitedHealth
UNH
$355B
$2.81M 0.84%
7,549
-10
-0.1% -$3.46K
WBA
30
DELISTED
Walgreens Boots Alliance
WBA
$2.79M 0.83%
50,810
+1,292
+3% +$63.9K
CMCSA icon
31
Comcast
CMCSA
$96.1B
$2.77M 0.82%
51,210
+15,629
+44% +$826K
HON icon
32
Honeywell
HON
$68.4B
$2.76M 0.82%
13,507
+753
+6% +$147K
XOM icon
33
ExxonMobil
XOM
$663B
$2.75M 0.82%
49,196
+137
+0.3% +$7.18K
NKE icon
34
Nike
NKE
$58.8B
$2.68M 0.8%
20,159
+781
+4% +$109K
WMT icon
35
Walmart Inc
WMT
$832B
$2.56M 0.76%
56,568
+2,979
+6% +$138K
LLY icon
36
Eli Lilly
LLY
$1.12T
$2.45M 0.73%
13,137
+1,019
+8% +$199K
ABBV icon
37
AbbVie
ABBV
$468B
$2.44M 0.73%
22,506
+754
+3% +$80.7K
GD icon
38
General Dynamics
GD
$102B
$2.38M 0.71%
13,119
+1,126
+9% +$184K
T icon
39
AT&T
T
$176B
$2.36M 0.7%
103,316
+8,053
+8% +$178K
INTC icon
40
Intel
INTC
$466B
$2.3M 0.68%
35,871
+1,155
+3% +$68.8K
SYK icon
41
Stryker
SYK
$125B
$2.23M 0.67%
9,177
+624
+7% +$150K
PG icon
42
Procter & Gamble
PG
$338B
$2.17M 0.65%
16,042
+516
+3% +$67.3K
MRK icon
43
Merck
MRK
$379B
$2.15M 0.64%
29,259
+26,588
+995% +$1.96M
JNJ icon
44
Johnson & Johnson
JNJ
$657B
$2.13M 0.63%
12,927
+551
+4% +$89.2K
BIIB icon
45
Biogen
BIIB
$32.5B
$2.12M 0.63%
7,561
+345
+5% +$93K
TROW icon
46
T. Rowe Price
TROW
$23.8B
$2.1M 0.62%
12,212
+511
+4% +$83.8K
SYY icon
47
Sysco
SYY
$39.8B
$2.05M 0.61%
26,032
+1,123
+5% +$87.1K
BMY icon
48
Bristol-Myers Squibb
BMY
$138B
$2.03M 0.6%
32,157
+878
+3% +$54.6K
MO icon
49
Altria Group
MO
$113B
$2.02M 0.6%
39,474
+2,746
+7% +$123K
KO icon
50
Coca-Cola
KO
$394B
$1.98M 0.59%
37,610
+2,350
+7% +$118K
1
2
3 4 5

Similar funds

SCM
Sirios Capital Management Boston, Massachusetts $822M AUM 44.91% 1-Year Est. Return
SCP
Sivia Capital Partners Mill Valley, California $822M AUM 48.82% 1-Year Est. Return
GSWM
Greenup Street Wealth Management Ann Arbor, Michigan $822M AUM 25.64% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
MGAM
McGowan Group Asset Management Dallas, Texas $823M AUM 27.48% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $823M AUM 36.99% 1-Year Est. Return
WRPWM
Werba Rubin Papier Wealth Management San Jose, California $824M AUM 24.76% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $824M AUM 40.45% 1-Year Est. Return

Leelyn Smith's Q1 2021 Portfolio in Review

As of Q1 2021, Leelyn Smith held 397 positions worth $336M, up 7.4% from $313M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Leelyn Smith deployed $15.2M of net new capital in Q1 2021, opening 32 new positions and adding to 145 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 4,717 shares worth $1.01M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Charles Schwab, an estimated $2.01M trimmed.

  • Leelyn Smith's largest Q1 2021 buy was Vertex Pharmaceuticals: 4,717 shares worth $1.01M.
  • Leelyn Smith added most to Invesco QQQ Trust in Q1 2021, an estimated $2.55M increase.
  • Leelyn Smith's biggest Q1 2021 reduction was Charles Schwab, cutting an estimated $2.01M.
  • Leelyn Smith fully exited Colgate-Palmolive in Q1 2021, selling an estimated $94K.
  • Leelyn Smith's ten largest holdings make up 41% of its $336M portfolio in Q1 2021.
  • Leelyn Smith opened 32 new positions and closed 9 in Q1 2021.
  • Leelyn Smith's portfolio value rose 7.4% quarter-over-quarter to $336M.

Based on Leelyn Smith's 13F filing for Q1 2021, filed 5 May 2021.